ロート製薬株式会社 · ROHTO PHARMACEUTICAL CO.,LTD.
Last · Tokyo¥2893.00+63.00 (+2.23%)close · yahoo · 6h ago
Market cap¥652.2B225.4M sh
P/E · TTM20.6fwd 17.3 · eps 140.40
Beta-0.41vs S&P 500
Div yield1.63%annual · TTM
52w range
¥2218.50¥3122.00
Volume1.0Msession
| Revenue | ¥343.7B |
|---|---|
| Operating income | ¥41.1B |
| Net income | ¥34.2B |
| Free cash flow | ¥32.8B |
| Operating margin | 12.0% |
| Net margin | 10.0% |
| Return on equity | 13.5% |
| Period | 2026 |
Loading chart…
Upcoming earnings
7:30 AM UTC+1
Period
Sep 2026
Est. EPS
$32.77
Est. revenue
89.2B
Earnings transcripts
Documents
FormReporting forFiledFlags